Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients : Analysis Using Evidence from the PIVOT Trial

Oddershede, Lars, Walker, Simon Mark orcid.org/0000-0002-5750-3691, Stöhr, Wolfgang et al. (4 more authors) (2016) Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients : Analysis Using Evidence from the PIVOT Trial. Pharmacoeconomics. 795–804. ISSN 1179-2027

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Springer 2016. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details
Dates:
  • Published (online): 10 March 2016
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York)
Depositing User: Pure (York)
Date Deposited: 09 May 2016 13:03
Last Modified: 06 Dec 2023 11:15
Published Version: https://doi.org/10.1007/s40273-016-0396-x
Status: Published online
Refereed: Yes
Identification Number: https://doi.org/10.1007/s40273-016-0396-x

Download

Filename: PIVOT_Economic_Evaluation_Paper_110116_no_tracked_changes.docx

Description: PIVOT Economic Evaluation Paper 110116- no tracked changes

Export

Statistics